Skip to content
★ Sign in to follow
MM

Meg McGilley

Somaxon Pharmaceuticals, Inc.
Total declarations
38
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (25 ops.)
€756k

Latest filing published 19 Feb 2009 for Somaxon Pharmaceuticals, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
25
Signal history

No signal scores available.

Meg McGilley: trading record in brief

All filings by Meg McGilley on record concern Somaxon Pharmaceuticals, Inc. Between 25 September 2006 and 17 February 2009, the trades on record add up to 38 filings.

Every open-market trade on record is a sale: 25 sales worth €756k. Besides market trades, the filings include 4 share grants and 9 option exercises.

The newest entry dates from 19 February 2009: a share grant, in Somaxon Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Meg McGilley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations36 total

25 of 36 declarations